Prevalence of doravirine cross-resistance in HIV-infected adults who failed first-line ART in China, 2014-18. Sun Z, Lan Y, Liang S, Wang J, et al. J Antimicrob Chemother 2022;77:1119-1124.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun Z, Lan Y, Liang S, Wang J, et al. Prevalence of doravirine cross-resistance in HIV-infected adults who failed first-line ART in China, 2014-18. J Antimicrob Chemother 2022;77:1119-1124.
PMID: 35134966